Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Nanotherapeutics for Neurological Disorders

Author(s): Sanjula Baboota and Javed Ali

Volume 26, Issue 19, 2020

Page: [2193 - 2194] Pages: 2

DOI: 10.2174/138161282619200520074049

Next »
[1]
A. Manish,, A. Bhawana,, A. Anupriya,. et al Cold atmospheric plasma as a novel therapeutic tool for the treatment of brain cancer. Curr Pharm Des 2020; 26(19): 2195-206.
[2]
N.C Eemaan,, PDK Pierre,, EC Yahya,, C du T Lisa,, P Viness. Carbon dots as nanotherapeutics for biomedical application. Curr Pharm Des 2020; 26(19): 2207-21.
[3]
Md Shadab,, K Shahid,, R.S Sanggetha,. et alCurrent status and challenges in rotigotine delivery. Curr Pharm Des 2020; 26(19): 2222-32.
[4]
G Bapi,, CR Davinaa,, P Manisha,, K Prashant,, AK Santosh,, C Hira. Nose to brain delivery of nanocarriers towards attenuation of demented condition. Curr Pharm Des 2020; 26(19): 2233-46.
[5]
S. Surbhi,, D Shweta. Neuropsychological disorders and their nanocarriers. Curr Pharm Des 2020; 26(19): 2247-56.
[6]
D Anmol, Narang. RS, KN Jasjeet. Recent advances in nanotherapeutic interventions for the treatment of alzheimer’s disease. Curr Pharm Des 2020; 26(19): 2257-79.
[7]
A Nidhi,, Q Zufika,, R Saleha,, B Sanjula,, A Javed. Orally administered nanotherapeutics for parkinson’s disease: an old delivery system yet more acceptable. Curr Pharm Des 2020; 26(19): 2280-90.
[8]
M Saurabh,, UA Muhammad,, FQ Farheen,. et alLigand conjugated targeted nanotherapeutics for treatment of neurological disorders. Curr Pharm Des 2020; 26(19): 2291-305.

Rights & Permissions Print Cite
Article Metrics
23
3
© 2024 Bentham Science Publishers | Privacy Policy